The Pituitary World News Podcast
Science
Today, Dr. Scott Struthers talks to PWN about paltusotine, their new once-a-day acromegaly oral drug candidate. Crinetics recently published results from the latest phase of the paltusotine clinical trial. He discussed the results and provided a fascinating look at the details and their learning from the data as they analyzed these initial results. He also shared the status of a new drug for Cushing's and Congenital Adrenal Hyperplasia (CAH), currently entering phase 2 of a clinical trial. Don't miss it!
For those following PWN, you may recall we recorded our first podcasts with Dr. Struthers when paltusotine entered its clinical trial in 2017. If you haven't heard it, I highly recommend it. It is really interesting to hear Dr. Struthers talk about their work on drugs for acromegaly and other neuroendocrine disorders and how the company has progressed since those early days. Also, if you'd like to learn more, listen to our podcast series on new drug development, "The Journey to a New Drug."
S1E14: Diagnosis of growth hormone deficiency
S1E13: Prolactinomas
S1E12: Hyperprolactinemia
S1E11: You asked (session 1)
S1E10: Insights on Diabetes Insipidus
S1E9: More on the Diabetes Insipidus Survey
S1E8: The doctor-patient relationship
S1E7: Acromegaly (part 2)
S1E6: Acromegaly (part 1)
S1E5: Adrenal Insufficiency
S1E4: Lab tests in Endocrinology
S1E3: Hormone replacement in women – Part 2
S1E2: Female Hormone Replacement – Part 1
S1E1: Excess mortality associated with hypopituitarism in adults
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain